MedPath

Sinecatechins

Generic Name
Sinecatechins
Brand Names
Veregen
Drug Type
Small Molecule
CAS Number
188265-33-0
Unique Ingredient Identifier
T432289GYZ
Background

Sinecatechins is a botanical drug product for topical use. It is a partially purified fraction of the water extract of green tea leaves from Camellia sinensis, and is a mixture of catechins and other green tea components. Catechins constitute 85 to 95% (by weight) of the total drug substance which includes more than 55% of Epigallocatechin gallate (EGCg), other catechin derivatives such as Epicatechin (EC), Epigallocatechin (EGC), Epicatechin gallate (ECg) and some additional minor catechin derivatives i.e. Gallocatechin gallate (GCg), Gallocatechin (GC), Catechin gallate (Cg), and Catechin (C). In addition to the known catechin components, it also contains gallic acid, caffeine, and theobromine which together constitute about 2.5% of the drug substance. The remaining amount of the drug substance contains undefined botanical constituents derived from green tea leaves.

Indication

For the topical treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients 18 years and older.

Associated Conditions
Condylomata Acuminata, Perianal Warts

Safety of Polyphenon E in Multiple Sclerosis Pilot Study

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2009-02-04
Last Posted Date
2013-06-27
Lead Sponsor
Louisiana State University Health Sciences Center in New Orleans
Target Recruit Count
10
Registration Number
NCT00836719
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Louisiana Health Sciences Center New Orleans, New Orleans, Louisiana, United States

Study of Polyphenon E in Addition to Erlotinib in Advanced Non Small Cell Lung Cancer

Phase 1
Terminated
Conditions
Non-Small Cell Lung Cancer
Interventions
First Posted Date
2008-06-30
Last Posted Date
2015-04-21
Lead Sponsor
Louisiana State University Health Sciences Center Shreveport
Target Recruit Count
11
Registration Number
NCT00707252
Locations
๐Ÿ‡บ๐Ÿ‡ธ

LSUHSC-Shreveport, Feist-Weiller Cancer Center, Shreveport, Louisiana, United States

A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2008-05-13
Last Posted Date
2017-09-21
Lead Sponsor
Louisiana State University Health Sciences Center Shreveport
Target Recruit Count
32
Registration Number
NCT00676793
Locations
๐Ÿ‡บ๐Ÿ‡ธ

LSU Health Sciences Center, Shreveport, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Columbia Presbyterian Hospital, New York, New York, United States

Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia

Phase 2
Completed
Conditions
Prostatic Hyperplasia
Interventions
Drug: Placebo
First Posted Date
2008-01-16
Last Posted Date
2019-10-04
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Target Recruit Count
97
Registration Number
NCT00596011
Locations
๐Ÿ‡บ๐Ÿ‡ธ

LSU Health Sciences Center, Feist-Weiller Cancer Center, Shreveport, Louisiana, United States

๐Ÿ‡บ๐Ÿ‡ธ

Jefferson Medical College - Department of Urology, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Chicago - Department of Surgery, Chicago, Illinois, United States

and more 7 locations

Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease

Phase 2
Completed
Conditions
Lung Cancer Prevention
Interventions
Dietary Supplement: green tea
Other: placebo
First Posted Date
2006-08-15
Last Posted Date
2013-11-28
Lead Sponsor
Sherry Chow
Target Recruit Count
178
Registration Number
NCT00363805
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Veterans Affairs Medical Center - Tucson, Tucson, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

Virginia G. Piper Cancer Center at Scottsdale Healthcare - Shea, Tucson, Arizona, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath